Cystic fibrosis-related diabetes

1 paper

Humans1

Trial sponsors

Jagdeesh Ullal
1 trialPhase 413 people
Masonic Cancer Center, University of Minnesota
2 trialsPhase 2/316 people
University of Minnesota
2 trialsPhase 2/316 people
University of Kansas Medical Center
1 trialPhase 230 people

Latest

1 in 12 months

Respiratory Medicine3 Sep

Pulmonary response to glucagon-like peptide-1 receptor agonist therapy in adults with cystic fibrosis-related diabetes: factors associated with improvement in FEV₁

Cohort study of 23 peopleGLP-1 receptor agonists